CN Patent

CN101541805A — 用于治疗疼痛和脂代射紊乱的氮杂环丁烷和氮杂环丁酮衍生物

Assigned to Merck Sharp and Dohme LLC · Expires 2009-09-23 · 17y expired

What this patent protects

本发明公开式(I)的化合物，其中Z 1 为－CH 2 －或－C(O)－，R 4 和R 5 为碳链(并且可任选一起形成C 2 桥)，u和v独立为0－3的整数，使得它们的和为3至5，R 2 为杂芳基，并且R 1 和R 3 如本文所限定。本发明还公开用式(I)的化合物治疗疼痛的方法和抑制胆固醇吸收的方法。

USPTO Abstract

本发明公开式(I)的化合物，其中Z 1 为－CH 2 －或－C(O)－，R 4 和R 5 为碳链(并且可任选一起形成C 2 桥)，u和v独立为0－3的整数，使得它们的和为3至5，R 2 为杂芳基，并且R 1 和R 3 如本文所限定。本发明还公开用式(I)的化合物治疗疼痛的方法和抑制胆固醇吸收的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101541805A
Jurisdiction
CN
Classification
—
Expires
2009-09-23
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.